It is a trading private limited company based in Surat, Gujarat, India, established in 2017.
2017 | Surat, Gujarat, India | ActiveKingbuild Pharmaceuticals Private Limited, a active private limited company, was established on 24 November 2017 in Surat, Gujarat, India. Engaging in specialty within the trading sector, it holds CIN: U51909GJ2017PTC099928. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Bikash Kumar Jena (Director), Rakesh Kumar Jena (Managing Director). Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Shop No-11,Ground Floor Green Orien,Jehangirabad Canal Road, Surat, Gujarat, 395005.
U51909GJ2017PTC099928
099928
24 November 2017
₹1.00 M
₹0.50 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Kingbuild Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bikash Kumar Jena | Director | 24 Nov 2017 | Current |
| Rakesh Kumar Jena | Managing Director | 24 Nov 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kingbuild Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 101.75% increase. The company also saw a substantial fall in profitability, with a 27.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 20.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Kingbuild Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kingbuild Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kingbuild Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kingbuild Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kingbuild Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.
Progress on Kingbuild Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Ahmedabad. was documented.
Bikash Kumar Jena was appointed as a Director was appointed as a Director on 24 Nov 2017 & has been associated with this company since 8 years 23 days . was recorded as a recent event.
Progress on Rakesh Kumar Jena was appointed as a Managing Director was appointed as a Managing Director on 24 Nov 2017 & has been associated with this company since 8 years 23 days . was documented.
Progress on Kingbuild Pharmaceuticals Private Limited was registered on 24 Nov 2017 with Roc Ahmedabad & aged 8 years 23 days as per MCA records. was documented.
The CIN of Kingbuild Pharmaceuticals Private Limited is U51909GJ2017PTC099928.
Kingbuild Pharmaceuticals Private Limited is headquartered at Shop No-11,Ground Floor Green Orien,Jehangirabad Canal Road, Surat, Gujarat, 395005.
Kingbuild Pharmaceuticals Private Limited was incorporated on 24 November 2017.
The current directors of Kingbuild Pharmaceuticals Private Limited are
The primary industry of Kingbuild Pharmaceuticals Private Limited is Trading.
Kingbuild Pharmaceuticals Private Limited is unlisted.
The authorized capital of Kingbuild Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Kingbuild Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX